Option Care Health Past Earnings Performance
Past criteria checks 3/6
Option Care Health has been growing earnings at an average annual rate of 68.2%, while the Healthcare industry saw earnings growing at 11.6% annually. Revenues have been growing at an average rate of 16.6% per year. Option Care Health's return on equity is 17.9%, and it has net margins of 6.1%.
Key information
68.2%
Earnings growth rate
68.1%
EPS growth rate
| Healthcare Industry Growth | 11.6% |
| Revenue growth rate | 16.6% |
| Return on equity | 17.9% |
| Net Margin | 6.1% |
| Next Earnings Update | 22 Feb 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Option Care Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 4,205 | 257 | 608 | 0 |
| 30 Jun 23 | 4,133 | 240 | 592 | 0 |
| 31 Mar 23 | 4,045 | 159 | 580 | 0 |
| 31 Dec 22 | 3,945 | 151 | 566 | 0 |
| 30 Sep 22 | 3,845 | 178 | 555 | 0 |
| 30 Jun 22 | 3,716 | 175 | 547 | 0 |
| 31 Mar 22 | 3,595 | 173 | 540 | 0 |
| 31 Dec 21 | 3,439 | 140 | 526 | 0 |
| 30 Sep 21 | 3,316 | 82 | 512 | 0 |
| 30 Jun 21 | 3,206 | 48 | 500 | 0 |
| 31 Mar 21 | 3,086 | 9 | 491 | 0 |
| 31 Dec 20 | 3,033 | -8 | 500 | 0 |
| 30 Sep 20 | 2,949 | -42 | 498 | 0 |
| 30 Jun 20 | 2,783 | -86 | 509 | 0 |
| 31 Mar 20 | 2,539 | -92 | 483 | 0 |
| 31 Dec 19 | 2,310 | -76 | 434 | 0 |
| 30 Sep 19 | 2,095 | -57 | 403 | 0 |
| 30 Jun 19 | 1,973 | -12 | 356 | 0 |
| 31 Mar 19 | 1,956 | -3 | 339 | 0 |
| 31 Dec 18 | 1,940 | -6 | 346 | 0 |
| 31 Dec 17 | 1,782 | 4 | 338 | 0 |
| 31 Dec 16 | 1,673 | 4 | 329 | 0 |
Quality Earnings: O2PC34 has a large one-off gain of $84.9M impacting its last 12 months of financial results to 30th September, 2023.
Growing Profit Margin: O2PC34's current net profit margins (6.1%) are higher than last year (4.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: O2PC34 has become profitable over the past 5 years, growing earnings by 68.2% per year.
Accelerating Growth: O2PC34's earnings growth over the past year (44.2%) is below its 5-year average (68.2% per year).
Earnings vs Industry: O2PC34 earnings growth over the past year (44.2%) exceeded the Healthcare industry -3%.
Return on Equity
High ROE: O2PC34's Return on Equity (17.9%) is considered low.